Product
SIM1811-03 or in combination with Sintilimab injection
1 clinical trial
2 indications
Indication
Advanced Solid TumorIndication
Cutaneous T-Cell LymphomaClinical trial
An Open-label, Phase I Trial of SIM1811-03 to Assess the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics in Subjects With Advanced TumorsStatus: Recruiting, Estimated PCD: 2025-06-30